CD 129 (Ranitidine Hydrochloride 150 mg)

Pill with imprint CD 129 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Ranitidine is used in the treatment of duodenal ulcer; duodenal ulcer prophylaxis; gerd; erosive esophagitis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CD 129

Ranitidine Hydrochloride

Imprint:

CD 129

Strength:

150 mg

Color:

Brown

Size:

15.00 mm

Shape:

Capsule-shape

Availability:

Rx and/or OTC

Drug Class:

H2 antagonists

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Dr. Reddy’s Laboratories Inc.

Inactive Ingredients:

• magnesium stearate
• microcrystalline cellulose
• sodium starch glycolate type A potato
• ferrosoferric oxide
• ferric oxide red
• ferric oxide yellow
• titanium dioxide
• gelatin

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
55111-0129	Dr. Reddy's Laboratories, Inc.
42291-0735	AvKare, Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer